Cost-effectiveness of thrombectomy with or without alteplase in large vessel occlusion stroke: a meta-analysis
Mô hình 15 năm tại 16 quốc gia cho thấy tính chi phí-hiệu quả của alteplase trước lấy huyết khối phụ thuộc thời gian…
Read more →Loại tài liệu
Mô hình 15 năm tại 16 quốc gia cho thấy tính chi phí-hiệu quả của alteplase trước lấy huyết khối phụ thuộc thời gian…
Read more →Direct-acting antivirals (DAAs) are modern treatments for chronic hepatitis C infection, but majority of available evidence on its treatment effect covers genotypes 1 to…
Read more →Objective: Breast cancer remains to be the globally leading female cancer. About 15% to 20% of breast cancers have human epidermal growth factor receptor…
Read more →Background Expanding chronic hepatitis B (CHB) testing through effective implementation strategies in primary- and community-care setting is crucial for elimination. Our study aimed to…
Read more →This systematic review aimed to identify neoadjuvant anti-human epidermal growth factor receptor 2 (HER2) therapies with the best balance between efficacy and safety. Methods:…
Read more →OBJECTIVE: This study investigated the efficacy and safety of pharmacologic interventions to prevent vertical transmission of the hepatitis B virus. DATA SOURCES: Medline, Cochrane,…
Read more →BACKGROUND: The benefit of intravenous thrombolysis with alteplase before endovascular thrombectomy (EVT) for acute ischemic stroke due to large vessel occlusion remains debated. In…
Read more →